Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2002
11/27/2002EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002EP1259511A1 3,9-diazabicyclo 3.3.1]nonane derivatives with analgesic activity
11/27/2002EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002EP1259509A1 Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo 1,2-a]pyrimidine-3-(n,n-dimethyl-acetamide) and intermediates
11/27/2002EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002EP1259236A1 Tyrosine kinase inhibitors
11/27/2002EP1259235A1 Tyrosine kinase inhibitors
11/27/2002EP1153050A4 Amino-ketone solid support templates
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382141A 1,8-naphthyridine derivatives
11/27/2002CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/27/2002CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
11/26/2002US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002US6486320 Preparation of camptothecin and of its derivatives
11/26/2002US6486191 Fungicidal activity
11/26/2002US6486188 Method of treatment for cardiovascular complications
11/26/2002US6486185 3-heteroarylidene-2-indolinone protein kinase inhibitors
11/26/2002US6486180 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2002US6486171 Useful in the treatment of some central nervous system disorders including as an antidepressant; 4-(1-(2-naphthyl)ethyl)-4- piperidinyl)thieno(3,2-c)pyridine, for example
11/26/2002US6486168 Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
11/26/2002US6486167 Heterocyclic cytotoxic agents
11/26/2002US6486153 Phenylindole derivatives as 5-HT2A receptor ligands
11/26/2002US6485704 Azo compound for type I pototherapy
11/26/2002CA2086643C Oxepane isomers of rapamycin useful as immunosuppressive agents
11/21/2002WO2002093164A2 Pyridylpyrimidine derivatives as effective compounds against prion diseases
11/21/2002WO2002092598A1 DIHYDROIMIDAZO [5,1-A]-$G(b)-CARBOLINE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINE
11/21/2002WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092596A1 Novel sulfonate substituted pyrazol pyridine dervivatives
11/21/2002WO2002092582A1 Protease-inhibitors
11/21/2002WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092086A1 Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists
11/21/2002WO2002092076A1 Substituted coumarins and quinolines as caspases activators
11/21/2002WO2002091830A1 Pyridinyl fused bicyclic amide as fungicides
11/21/2002WO2002070513A9 Methods for the preparation of mirtazapine intermediates
11/21/2002WO2002062290A3 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
11/21/2002WO2002022598A8 Quinolinone derivatives as tyrosine kinase inhibitors
11/21/2002US20020173664 An 3-acyl-4-substituted-oxazolidin-2,5-dione that readily reacts with nucleophilic reagents such as free amino acids; use in peptide synthesis for example
11/21/2002US20020173659 Indole derivatives for the treatment of osteoporosis
11/21/2002US20020173655 Thioether substituted imidazoquinoline or tetrahydroimdazoquinoline compounds induce the biosynthesis of cytokines such as interferon and useful for treating viral disease in an animal
11/21/2002US20020173654 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor, and useful as viricides and antitumor agents
11/21/2002US20020173653 Antiviral and antitumor properties; immunomodulators and for inducing cytokine biosynthesis in animals
11/21/2002US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002US20020173507 Antiproliferative agents; apoptosis; anticancer agents
11/21/2002US20020173504 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds
11/21/2002US20020173503 Substituted pyridoindoles as serotonin agonists and antagonists
11/21/2002US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002US20020173445 Selective androgen receptor modulators and methods for their identification, design and use
11/21/2002US20020170594 --Metal Complex Having Beta-Diketonate, Process for Production Thereof, Photoelectric Conversion Element, and Photochemical Cell--
11/21/2002US20020170121 Indolizine derivatives, compositions comprising at least one coupler chosen from indolizine derivatives and at least one oxidation base, and methods for using same
11/21/2002DE10124041A1 New peptide-type compounds, useful as protease, especially thrombin, inhibitors for treating e.g. thrombosis and cardiac infarct
11/21/2002CA2447588A1 Dihydroimidazo [5,1-a]-$g(b)-carboline derivatives, method for preparing same and use thereof as medicine
11/21/2002CA2446988A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/20/2002EP1258480A1 Pharmaceutical use of N-Carbamoylazole derivatives
11/20/2002EP1258252A1 Integrin expression inhibitors
11/20/2002EP1258250A1 Nerve protective drugs
11/20/2002EP1258244A1 High affinity ligands for nociceptin receptor ORL-1
11/20/2002EP1257551A1 Heterocyclic compounds and their use as parp inhibitors
11/20/2002EP1257543A1 Pyridinylimidazoles
11/20/2002EP1257537A1 Therapeutic morpholino-substituted compounds
11/20/2002EP1257278A1 The use of mirtazapine for the treatment of sleep disorders
11/20/2002EP1257276A1 Antiviral azaindole derivatives
11/20/2002EP0912568B1 imidazopyridines
11/20/2002EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/20/2002EP0882049B1 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
11/20/2002EP0593603B1 Bicyclic fibrinogen antagonists
11/19/2002US6482949 Colormetric sensor compositions and methods
11/19/2002US6482829 Central nervous system disorders; heeadaches, antiinflammatory agents
11/19/2002US6482825 Growth-hormone secretagogues
11/14/2002WO2002090360A1 Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
11/14/2002WO2002090356A2 Method for the production of zolpidem
11/14/2002WO2002090355A1 N-aroyl cyclic amines
11/14/2002WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090325A2 Benzazepinone alpha v integrin receptor antagonists
11/14/2002WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002WO2002089807A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection
11/14/2002WO2002089806A1 Heterobicycles fkbp-ligands
11/14/2002WO2002089793A1 Sulfonamides
11/14/2002WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002WO2002089780A2 Antiviral compounds
11/14/2002WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002WO2002089729A2 Fused heterocyclic compounds
11/14/2002WO2002048146A3 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
11/14/2002WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002WO2001097787A3 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
11/14/2002US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002US20020169320 Tetrahydropyridoethers
11/14/2002US20020169200 Antitumor, antiinflammatory and antiarthritic agents, treating metastasis, restenosis, osteoporosis, inflammation, macular degeneration, and diabetic retinopathy
11/14/2002US20020169182 Neurotrophin antagonist compositions
11/14/2002US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002US20020169155 A nitrogen-ring containing triheterocyclic compound is useful for treating a disease associated with aberrant leukocyte recruitment and/or activation
11/14/2002US20020169111 Reversal of multidrug resistance in human colon carcinoma cells
11/14/2002DE10122894A1 New pyrazolo(3,4-b)pyridin-3-yl)-5-pyrimidinyl sulfonates, are soluble guanyl cyclase stimulants useful e.g. for treating cardiovascular, thromboembolic or central nervous system diseases
11/14/2002DE10121638A1 Verfahren zur Herstellung von Imidazopyridinen Process for the preparation of imidazopyridines
11/14/2002CA2446795A1 Sulfamide, sulfamate, sulfonamide, urea, amide, alpha, alpha-difluoro amide oxalyl diamide, and heterobicycles fkbp-binding ligands
11/14/2002CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/14/2002CA2446396A1 N-aroyl cyclic amines
11/14/2002CA2446351A1 Fused heterocyclic compounds
11/14/2002CA2445923A1 Arylsulfonamide ethers, and methods of use thereof
11/14/2002CA2445766A1 Improved process for preparing zolpidem
1 ... 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 ... 646